Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lamb

Showing results (621-630 of 674) with videos related to

Pageof 68
Sort By:
Gut|June 2, 2026
Recent advances in our understanding of the gut microbiome: an analysis from the Gut Microbiota for Health Expert Panel of the British Society of GastroenterologyJames L Alexander, Benjamin H Mullish, Linda Thomas, et al.
Nature Microbiology|March 17, 2026
Clostridia from preterm infants metabolize human milk oligosaccharides to suppress pathobionts and modulate intestinal function in organoidsJonathan A Chapman, Andrea C Masi, Lauren C Beck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2022
Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA TrialAndrés Elía, Leo Saldain, Silvia I Vanzulli, et al.
Scientific Reports|March 19, 2016
Clec16a is Critical for Autolysosome Function and Purkinje Cell SurvivalVeronika Redmann, Christopher A Lamb, Seungmin Hwang, et al.
BMJ Open Gastroenterology|April 7, 2026
The 2026 IBD UK Standards of healthcare service design and delivery for adults and children living with Crohn's disease and ulcerative colitisChristopher A Lamb, Catherine Picton, Ian Arnott, et al.
Gut|July 28, 2022
Vaccine escape, increased breakthrough and reinfection in infliximab-treated patients with IBD during the Omicron wave of the SARS-CoV-2 pandemicNicholas A Kennedy, Malik Janjua, Neil Chanchlani, et al.
Frontline Gastroenterology|September 3, 2020
Organisational changes and challenges for inflammatory bowel disease services in the UK during the COVID-19 pandemicNicholas A Kennedy, Richard Hansen, Lisa Younge, et al.
Clinical Immunology (Orlando, Fla.)|April 4, 2024
Identification of connective tissue disease autoantibodies and a novel autoantibody anti-annexin A11 in patients with "idiopathic" interstitial lung diseaseSarah L Tansley, Fionnuala McMorrow, Caroline V Cotton, et al.
Gastroenterology|November 3, 2015
Association Between Response to Etrolizumab and Expression of Integrin αE and Granzyme A in Colon Biopsies of Patients With Ulcerative ColitisGaik W Tew, Jason A Hackney, Deena Gibbons, et al.
Lancet (London, England)|May 13, 2014
Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trialSéverine Vermeire, Sharon O'Byrne, Mary Keir, et al.
Pageof 68

Showing results (621-630 of 674) with videos related to

Sort By:
Pageof 68
Gut|June 2, 2026
Recent advances in our understanding of the gut microbiome: an analysis from the Gut Microbiota for Health Expert Panel of the British Society of GastroenterologyJames L Alexander, Benjamin H Mullish, Linda Thomas, et al.
Nature Microbiology|March 17, 2026
Clostridia from preterm infants metabolize human milk oligosaccharides to suppress pathobionts and modulate intestinal function in organoidsJonathan A Chapman, Andrea C Masi, Lauren C Beck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2022
Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA TrialAndrés Elía, Leo Saldain, Silvia I Vanzulli, et al.
Scientific Reports|March 19, 2016
Clec16a is Critical for Autolysosome Function and Purkinje Cell SurvivalVeronika Redmann, Christopher A Lamb, Seungmin Hwang, et al.
BMJ Open Gastroenterology|April 7, 2026
The 2026 IBD UK Standards of healthcare service design and delivery for adults and children living with Crohn's disease and ulcerative colitisChristopher A Lamb, Catherine Picton, Ian Arnott, et al.
Gut|July 28, 2022
Vaccine escape, increased breakthrough and reinfection in infliximab-treated patients with IBD during the Omicron wave of the SARS-CoV-2 pandemicNicholas A Kennedy, Malik Janjua, Neil Chanchlani, et al.
Frontline Gastroenterology|September 3, 2020
Organisational changes and challenges for inflammatory bowel disease services in the UK during the COVID-19 pandemicNicholas A Kennedy, Richard Hansen, Lisa Younge, et al.
Clinical Immunology (Orlando, Fla.)|April 4, 2024
Identification of connective tissue disease autoantibodies and a novel autoantibody anti-annexin A11 in patients with "idiopathic" interstitial lung diseaseSarah L Tansley, Fionnuala McMorrow, Caroline V Cotton, et al.
Gastroenterology|November 3, 2015
Association Between Response to Etrolizumab and Expression of Integrin αE and Granzyme A in Colon Biopsies of Patients With Ulcerative ColitisGaik W Tew, Jason A Hackney, Deena Gibbons, et al.
Lancet (London, England)|May 13, 2014
Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trialSéverine Vermeire, Sharon O'Byrne, Mary Keir, et al.
Pageof 68